Acceleron Pharma's IPO

Acceleron Pharma raised a round of funding on September 19, 2013. Investors include Public.

Acceleron Pharma is a biopharmaceutical company committed to discover, develop, manufacture and commercialize protein therapeutics for orphan diseases and cancer. Acceleron utilizes biotherapeutic tec…

Articles about Acceleron Pharma's IPO: